Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tom Grogan"'
Autor:
Pavani Chalasani, Shalini Singh, Robert B. Livingston, Dea Nagy, Michael Barnes, AF Baker, R Ridder, E Weterings, Tom Grogan, Ray B. Nagle, S Kandavel
Publikováno v:
Cancer Research. 76:P4-07
Background: Homologous recombination deficiency (HRD) in cancer cells can occur due to mutations (germline or sporadic), methylation or other epigenetic causes. HRD leads to a defect in the conservative, error-free DNA repair mechanism and is associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c22301c4a5de632d0d2cfb037fafe681
https://doi.org/10.1158/1538-7445.sabcs15-p4-07-07
https://doi.org/10.1158/1538-7445.sabcs15-p4-07-07
Autor:
James Rickert, Dwight W. Burney, Alexandra E. Page, Rob Rutherford, Paul E. Levin, Tom Grogan, Tom Boniface, Mark Piasio
Publikováno v:
Clinical Orthopaedics & Related Research. 475:2346-2347
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a2ada64a83e1f30ac1c6df3b511e8b8
https://doi.org/10.1007/s11999-017-5428-0
https://doi.org/10.1007/s11999-017-5428-0
Autor:
Mary Padilla, Isaac Bai, Tom Grogan, J. Ostrem, C. Garcia, Jim Ranger-Moore, Isabell Loftin, Rachel Miller, Abigail McElhinny
Publikováno v:
Cancer Research. 71:P5-11
Background: Amplification and/or HER2 overexpression is associated with poor clinical outcome for patients with invasive breast carcinoma. Determination of HER2 status dictates eligibility of patients for trastuzumab (Herceptin) therapy, which has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c48041e00e1b1765c990d02452c13d5
https://doi.org/10.1158/0008-5472.sabcs11-p5-11-10
https://doi.org/10.1158/0008-5472.sabcs11-p5-11-10
Autor:
James Pettay, Tom Grogan, Marek Skacel, Richard D. Powell, David G. Hicks, Raymond R. Tubbs, James F. Hainfeld
Publikováno v:
The Histochemical Journal. 35:589-594
Profiling the amplification and over-expression of the HER2 gene is a key component for defining the prognosis and management of invasive breast carcinoma. Clinical laboratory testing for HER2 gene amplification and over expression has been complicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e640212c50145cc4dc29ba2f3f0acc7
https://doi.org/10.1007/s10735-004-2191-9
https://doi.org/10.1007/s10735-004-2191-9
Publikováno v:
Journal of molecular histology. 35(6)
Diagnostic anatomic pathologists play an important role in the care of patients through their careful evaluation of morphological features in routinely prepared histological sections stained with Hematoxylin and Eosin. Morphological assessment of tis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284263e9745f669f7ef4c7a2f67dd7bb
https://pubmed.ncbi.nlm.nih.gov/15614613
https://pubmed.ncbi.nlm.nih.gov/15614613
Autor:
Dea Nagy, Michael Otter, Francesca Demichelis, Connie Cortez, Phil Miller, Kassie Smith, Tom Grogan, Ubaradka Sathyanarayana, Krystyn Pozarowski, Raymond Nagle, Gary Pestano, Ryan Dittamore, Steve Yun, Kelly Christopherson, Maria A. Svensson, Janice Riley, Karl Garsha, Nallasivam Palaniswamy, Mark A. Rubin
Publikováno v:
Cancer Research. 71:2218-2218
The identification of patients who will benefit from therapy is one of the more difficult questions in prostate cancer disease management. Approximately 60% of men with diagnosed prostate cancer will have an ETS rearranged tumor foci. The prostate ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::388459fe4db7b91303b16423a3f44be5
https://doi.org/10.1158/1538-7445.am2011-2218
https://doi.org/10.1158/1538-7445.am2011-2218